Amylyx Prices Upsized $500 Million Stock Offering Following Positive Avexitide Data

Company: Amylyx Pharmaceuticals · Ticker: AMLX · Event Type: Upsized Public Offering · Lead Asset: Avexitide · Date: August 21, 2026 Summary Amylyx Pharmaceuticals priced an upsized public offering of 14.09 million shares at $35.50 per share, raising roughly $500.2 million in gross proceeds (approximately…